They found that CD22, CD23, FMC-7, and CD5 expression could be used to diagnose CLL, MCL, and CD5−/CD10− lymphoma but could not differentiate MCL from atypical CLL. Here, CD5 is linked to B-cell chronic lymphocytic leukemia.